NF-κB inhibition radiosensitizes Ki-Ras-transformed cells to ionizing radiation

  • Bo Yeon Kim
  • , Osong Kwon
  • , Sun Ok Kim
  • , Min Soo Kim
  • , Beom Seok Kim
  • , Won Keun Oh
  • , Gun Do Kim
  • , Mira Jung
  • , Jong Seog Ahn*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

63 Citations (Scopus)

Abstract

Most cancer cells show resistance to ionizing radiation (IR)-induced cell death. Recently, Ki-Ras was reported to be responsible for the increased radioresistance. We report here that inhibition of IR-induced activaton of nuclear transcription factor kappa B (NF-κB) but not of either Akt or MAPK kinase (MEK), increased the radiosensitization of Ki-Ras transformed human prostate epithelial 267B1/K-ras cells. Proteosome inhibitor-1 (Pro1) reduced NF-κB activation, and this inhibition was accompanied by increased levels of cytoplasmic IκBα and p65/RelA. However, translocation of p50/ NF-κB1 did not occur on exposure to IR, suggesting the cell-specific involvement of p50 in radiation signaling. Clonogenic cell survival and soft agar assays further confirmed the increased radiosensitivity of 267B1/K-ras cells by proteosome inhibition. In addition, proteosome inhibition enhanced the IR-induced degradation of apoptotic protein caspases 8 and 3, with the level of antiapoptotic protein Bcl-2 being unaffected, suggesting the involvement of an apoptotic process in IR-induced cell death of 267B1/K-ras cells. LY294002 and PD98059, specific inhibitors of phosphatidylinositol-3-kinase (PI3K) and MEK, respectively however, did not affect the radiosensitization. All these results suggest an application of blocking NF-κB activation pathway to the development of anticancer therapeutics in IR-induced radiotherapy of Ki-Ras-transformed cancer cells.

Original languageEnglish
Pages (from-to)1395-1403
Number of pages9
JournalCarcinogenesis
Volume26
Issue number8
DOIs
Publication statusPublished - 2005 Aug
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported by Pharmacogenomics Program from the Ministry of Health and Welfare (BGW0200311), Molecular and Cellular BioDiscovery Research Program from the Ministry of Science and Technology (Grant M1-0311-00-0023) and KRIBB Research Initiative Program.

ASJC Scopus subject areas

  • Cancer Research

Fingerprint

Dive into the research topics of 'NF-κB inhibition radiosensitizes Ki-Ras-transformed cells to ionizing radiation'. Together they form a unique fingerprint.

Cite this